Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4

Anny Kretschmer,Kristin Moepert,Sibylle Dames,Maria Sternberger,Joerg Kaufmann,Anke Klippel
DOI: https://doi.org/10.1038/sj.onc.1206791
IF: 8.756
2003-10-02
Oncogene
Abstract:Smad transcription factors mediate the growth inhibitory effect of transforming growth factor-β (TGF-β) in many cell types. Mutational inactivation of Smads has been correlated with loss of responsiveness to TGF-β-mediated signal transduction. In this study, we compare the contribution of individual Smads to TGF-β-induced growth inhibition and endogenous gene expression in isogenic cellular backgrounds. Smad2, Smad3 and Smad4 expression were selectively inhibited in differentiation-competent cells by using improved antisense molecules. We found that TGF-β mediates its inhibitory effect on HaCaT keratinocyte cell growth predominantly through Smad3. Inhibition of Smad3 expression was sufficient to interfere with TGF-β-induced cell cycle arrest and to induce or suppress endogenous cell cycle regulators. Inhibition of Smad4 expression exhibited a partial effect, whereas inhibition of Smad2 expression had no effect. By gene expression profiling, we identified TGF-β-dependent genes that are differentially regulated by Smad2 and Smad3 under regular growth conditions on a genome-wide scale. We show that Smad2, Smad3 and Smad4 contribute to the regulation of TGF-β responses to varying extents, and demonstrate, in addition, that these Smads exhibit distinct roles in different cell types.
oncology,genetics & heredity,biochemistry & molecular biology,cell biology
What problem does this paper attempt to address?